FDA clears Zeta’s robotic TMS system, but the real test begins inside busy clinics
Zeta Surgical wins FDA clearance for its robotic TMS system, advancing automated coil positioning and motion compensation in neuromodulation clinics.
Zeta Surgical wins FDA clearance for its robotic TMS system, advancing automated coil positioning and motion compensation in neuromodulation clinics.
The legal fight over Kadima Neuropsychiatry Institute tests NRx Pharmaceuticals’ acquisition discipline, financing credibility and evolving interventional psychiatry strategy.
NRx’s HOPE Therapeutics begins Zeta-guided TMS treatments, bringing AI-powered image guidance into outpatient depression care workflows.
Soterix Medical wins FDA clearance for SPRY TMS in treatment-resistant major depression. What the clearance means for the neuromodulation market. Read the analysis.
Serenity expands ketamine therapy in Florida. Find out how this signals a shift in psychiatric care access and what clinicians are watching next.